|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 239/70 | |
| A61K 31/496 |
| (11) | Patento numeris | 2694485 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12765234.5 |
| Europos patento paraiškos padavimo data | 2012-03-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-02-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/031665 |
| Data | 2012-03-30 |
| (87) | Numeris | WO 2012/135750 |
| Data | 2012-10-04 |
| (30) | Numeris | Data | Šalis |
| 201161470803 P | 2011-04-01 | US | |
| 201161470624 P | 2011-04-01 | US |
| (72) |
HOEFLICH, Klaus, US
MERCHANT, Mark, US
|
| (73) |
Genentech, Inc.,
One DNA Way, South San Francisco, CA 94080-4990,
US
|
| (54) | COMBINATION OF AKT INHIBITOR COMPOUND AND VEMURAFENIB FOR USE IN THERAPEUTIC TREATMENTS |
| COMBINATION OF AKT INHIBITOR COMPOUND AND VEMURAFENIB FOR USE IN THERAPEUTIC TREATMENTS |